BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Mental Health Issues in Pediatric Neuromuscular Disease

Activity Snapshot

Activity Type: 
Print/PDF
Release Date: 
Friday, January 1, 2021
Sponsor Information: 

This program is supported in part by independent educational grants from Mitsubishi Tanabe Pharma America, Inc. and Biogen

Faculty

Hillary Zebberman, LCSW, MSW
Hillary Zebberman, LCSW, MSW
Clinical Social Worker, The Pediatric Neuromuscular Clinic at UCLA
Aravindhan Veerapandiyan, MD
Aravindhan Veerapandiyan, MD
Pediatric Neurologist Arkansas Children’s Hospital
Mental Health Issues in Pediatric Neuromuscular Disease
Activity Overview: 

The Medical Education team has partnered with Hillary Zebberman from the Pediatric Neuromuscular Clinic at UCLA and Aravindhan Veerapandiyan from Arkansas Children’s Hospital to create a detailed presentation of best practices in mental health care for pediatric patients with neuromuscular disease (NMD). These slides will include an overview of the biological and psychosocial issues that impact the mental health and emotional needs of adolescents, as well as guidance on assessing the mental health needs of this population and incorporating these considerations into the treatment plan.

Learning Objectives: 
  • Overview of Mental Health in Pediatric NMD
  • Contributors to Mental Health Issues in NMD
  • Unique Aspects of Psychological Care in the Pediatric NMD Patient Population
  • Management of Mental Health Issues for Children With NMD